Berks Hematology Oncology Associates is a clinical research site located in Reading, Pennsylvania, United States 19612.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Berks Hematology Oncology Associates has participated in 2 clinical trials.
Therapeutic areas: Multiple Myeloma, Chronic Lymphocytic Leukemia.
Sponsors: Celgene.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Reading
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Berks Hematology Oncology Associates has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Berks Hematology Oncology Associates has 2 clinical trials on record. Their work covers Multiple Myeloma, Chronic Lymphocytic Leukemia.
Berks Hematology Oncology Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.